| Brittany Ward, APNP | |
|
2424 S 90th St Ste 300, West Allis, WI 53227-2455 | |
| (414) 389-2338 | |
| Not Available |
| Full Name | Brittany Ward |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 2424 S 90th St Ste 300, West Allis, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174037667 | NPI | - | NPPES |
| 100082738 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 8010 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Allis Memorial Hospital | West allis, WI | Hospital |
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Colorectal cancer is the most prevalent malignant tumor in Spain. It is known that factors such as diet and intestinal inflammation play an important role in its occurrence, but direct links between nutrients, inflammation and colorectal cancer are poorly described.
A patient blood management program designed to limit the amount of transfused blood orthopedic patients undergoing common surgeries such as hip and knee replacement receive was associated with fewer transfusions, reduced blood use and improved outcomes, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed journal of the American Society of Anesthesiologists.
Cancer is an unwanted experiment in progress. As the disease advances, tumor cells accumulate mutations, eventually arriving at ones that give them the insidious power to grow uncontrollably and spread. Distinguishing drivers of cancer from benign mutations open opportunities for developing targeted cancer therapies.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
› Verified 2 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Colorectal cancer is the most prevalent malignant tumor in Spain. It is known that factors such as diet and intestinal inflammation play an important role in its occurrence, but direct links between nutrients, inflammation and colorectal cancer are poorly described.
A patient blood management program designed to limit the amount of transfused blood orthopedic patients undergoing common surgeries such as hip and knee replacement receive was associated with fewer transfusions, reduced blood use and improved outcomes, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed journal of the American Society of Anesthesiologists.
Cancer is an unwanted experiment in progress. As the disease advances, tumor cells accumulate mutations, eventually arriving at ones that give them the insidious power to grow uncontrollably and spread. Distinguishing drivers of cancer from benign mutations open opportunities for developing targeted cancer therapies.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
› Verified 2 days ago
| Entity Name | Lakeshore Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003861188 PECOS PAC ID: 7719890730 Enrollment ID: O20031106000481 |
News Archive
Colorectal cancer is the most prevalent malignant tumor in Spain. It is known that factors such as diet and intestinal inflammation play an important role in its occurrence, but direct links between nutrients, inflammation and colorectal cancer are poorly described.
A patient blood management program designed to limit the amount of transfused blood orthopedic patients undergoing common surgeries such as hip and knee replacement receive was associated with fewer transfusions, reduced blood use and improved outcomes, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed journal of the American Society of Anesthesiologists.
Cancer is an unwanted experiment in progress. As the disease advances, tumor cells accumulate mutations, eventually arriving at ones that give them the insidious power to grow uncontrollably and spread. Distinguishing drivers of cancer from benign mutations open opportunities for developing targeted cancer therapies.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Ward, APNP 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 329-4979 | Brittany Ward, APNP 2424 S 90th St Ste 300, West Allis, WI 53227-2455 Ph: (414) 389-2338 |
News Archive
Colorectal cancer is the most prevalent malignant tumor in Spain. It is known that factors such as diet and intestinal inflammation play an important role in its occurrence, but direct links between nutrients, inflammation and colorectal cancer are poorly described.
A patient blood management program designed to limit the amount of transfused blood orthopedic patients undergoing common surgeries such as hip and knee replacement receive was associated with fewer transfusions, reduced blood use and improved outcomes, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed journal of the American Society of Anesthesiologists.
Cancer is an unwanted experiment in progress. As the disease advances, tumor cells accumulate mutations, eventually arriving at ones that give them the insidious power to grow uncontrollably and spread. Distinguishing drivers of cancer from benign mutations open opportunities for developing targeted cancer therapies.
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
› Verified 2 days ago
Paul Facchiano, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6609 W Greenfield Ave, West Allis, WI 53214 Phone: 414-257-8500 | |
Michelle Cyr, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2514 S 102nd St Ste 160, West Allis, WI 53227 Phone: 414-255-0300 | |
Autumn D Unrein, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2424 S 90th St Fl 2, West Allis, WI 53227 Phone: 414-328-8777 Fax: 414-328-8110 | |
Stephanie Schell, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2424 S 90th St Fl 3, West Allis, WI 53227 Phone: 414-328-8270 Fax: 414-328-8275 | |
Katelyn Nieman, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2514 S 102nd St Ste 160, West Allis, WI 53227 Phone: 414-255-0340 Fax: 855-342-0199 | |
Mr. Joseph Kozlosky, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10827 W Lincoln Ave, West Allis, WI 53227 Phone: 414-541-6010 Fax: 414-541-5509 | |
John Thomas Olstad, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1706 S 68th St, West Allis, WI 53214 Phone: 414-667-4800 |